Ocugen, Inc. (OCGN) Key Metrics
OCGN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $264.6M
- Enterprise value
- $424.6M
- P/E (TTM)
- —
- Forward P/E
- 13.1
- PEG ratio
- —
- Price / sales
- 57.8 10-yr median 72.8
- Price / book
- 75.9 10-yr median 7.4
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 2.27
OCGN key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsOCGN valuation Price multiples at each fiscal year-end price.
OCGN returns How much profit the business earns on the capital it uses.
OCGN per-share figures Results divided by the shares outstanding at year-end.
OCGN financial health Debt, liquidity and how easily interest is covered.
OCGN efficiency & capital use Working capital cycle and where the cash goes.
OCGN valuation history
OCGN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
OCGN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
OCGN cash returned to shareholders
OCGN price vs earnings per share
OCGN key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $405.2M | $218.2M | $140.5M | $279.0M | $887.3M | $205.4M | — | — | — | — |
| Enterprise value | $419.8M | $192.1M | $108.0M | $194.4M | $795.7M | $183.8M | — | — | — | — |
| Price / sales | 91.8 | 53.8 | 23.3 | 112.1 | — | — | — | — | — | — |
| Price / book | — | 7.4 | 3.5 | 3.8 | 9.3 | 9.5 | — | — | — | — |
| EV / sales | 95.1 | 47.4 | 17.9 | 78.1 | — | — | — | — | — | — |
| Earnings yield | −16.7% | −24.8% | −44.9% | −27.9% | −6.6% | −10.6% | — | — | — | — |
| Free cash flow yield | −14.1% | −20.9% | −51.6% | −23.1% | −5.5% | −7.3% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | — | — | — | — | 0.0% | 0.0% | — | — | — | — |
| Share price at fiscal year-end | $1.35 | $0.81 | $0.57 | $1.30 | $4.55 | $1.83 | $0.52 | $5.30 | $123.00 | $100.20 |
| Per share | ||||||||||
| Revenue per share | $0.01 | $0.01 | $0.02 | $0.01 | $0.00 | $0.00 | — | — | — | — |
| Earnings per share | −$0.23 | −$0.20 | −$0.26 | −$0.36 | −$0.30 | −$0.19 | — | — | — | — |
| Operating cash flow per share | −$0.19 | −$0.16 | −$0.25 | −$0.28 | −$0.25 | −$0.13 | — | — | — | — |
| Free cash flow per share | −$0.19 | −$0.17 | −$0.30 | −$0.30 | −$0.25 | −$0.13 | — | — | — | — |
| Cash per share | $0.06 | $0.22 | $0.16 | $0.42 | $0.49 | $0.21 | — | — | — | — |
| Book value per share | −$0.04 | $0.11 | $0.17 | $0.34 | $0.49 | $0.19 | — | — | — | — |
| Tangible book value per share | −$0.04 | $0.11 | $0.17 | $0.34 | $0.49 | $0.19 | — | — | — | — |
| Capex per share | $0.00 | $0.01 | $0.04 | $0.02 | $0.00 | $0.00 | — | — | — | — |
| Debt per share | $0.11 | $0.12 | $0.03 | $0.03 | $0.02 | $0.02 | — | — | — | — |
| Shares outstanding | 300.2M | 271.0M | 244.3M | 214.6M | 195.0M | 112.2M | — | — | — | — |
| Change in shares outstanding | +10.8% | +10.9% | +13.9% | +10.0% | +73.8% | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | −154.0% | −110.1% | −91.7% | −99.5% | −134.0% | −383.4% | — | — | −77.6% |
| Return on invested capital (ROIC) | — | −741.7% | — | — | — | −674.9% | — | — | — | — |
| Return on assets (ROA) | −107.7% | −73.5% | −72.8% | −72.6% | −87.7% | −98.8% | −118.3% | −60.7% | −112.1% | −44.5% |
| Return on tangible assets | −155.9% | −65.6% | −97.7% | −71.6% | −55.2% | −79.7% | −120.4% | −49.6% | −239.4% | −44.9% |
| Financial health | ||||||||||
| Total debt | $33.1M | $32.5M | $6.9M | $6.4M | $3.3M | $2.5M | $1.4M | $238,000 | $178,000 | $761,000 |
| Cash & short-term investments | $18.6M | $58.5M | $39.5M | $90.9M | $95.0M | $24.0M | $7.4M | $15.5M | $8.0M | $31.9M |
| Net debt | $14.6M | −$26.0M | −$32.5M | −$84.6M | −$91.7M | −$21.5M | −$6.0M | −$15.3M | −$7.8M | −$31.1M |
| Debt / equity | — | 1.10 | 0.17 | 0.09 | 0.03 | 0.12 | 0.13 | — | — | 0.06 |
| Debt / assets | 0.76 | 0.39 | 0.11 | 0.06 | 0.03 | 0.09 | 0.08 | 0.01 | 0.02 | 0.02 |
| Current ratio | 1.06 | 2.86 | 2.51 | 3.45 | 14.66 | 7.16 | 3.47 | 5.71 | 2.15 | 6.20 |
| Quick ratio | 1.06 | 2.86 | 2.51 | 3.45 | 13.95 | 7.16 | 3.47 | 5.71 | 2.15 | 6.20 |
| Interest coverage | -12.1 | -79.6 | — | -24.1 | -734.5 | -29.5 | -8.0 | -184.7 | -186.2 | -505.1 |
| Working capital | $1.3M | $40.1M | $25.9M | $70.0M | $95.6M | $22.3M | $11.2M | $13.5M | $4.4M | $26.9M |
| Invested capital | $2.4M | $3.6M | $8.0M | −$10.6M | $4.2M | $1,000 | $5.0M | −$15.8M | −$19.1M | −$17.6M |
| Tangible asset value | −$12.2M | $29.6M | $40.6M | $74.0M | $95.8M | $21.6M | $11.0M | −$458,000 | −$11.3M | $13.6M |
| Net current asset value | −$31.3M | $8.9M | $19.0M | $63.8M | $92.7M | $20.1M | $10.0M | −$1.5M | −$14.1M | $9.6M |
| Graham net-net per share | −$0.12 | $0.02 | $0.06 | $0.26 | $0.47 | $0.16 | — | — | — | — |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | $6.8M | — | — | — |
| Share buybacks (net) | — | — | — | — | $0 | $0 | $47,864 | $0 | $0 | $0 |
| Capex / revenue | 4.2% | 83.5% | 173.6% | 179.1% | 4,096.9% | 713.5% | 69.1% | — | — | — |
| Capex / depreciation | 0.08 | 1.72 | 14.88 | 9.29 | 4.10 | 3.01 | 0.49 | 40.57 | 0.18 | 0.19 |
| Stock-based compensation / revenue | 174.6% | 183.2% | 152.7% | 423.7% | 30,357.8% | 1,534.9% | 2,074.4% | — | — | — |
| R&D / revenue | 900.7% | 792.3% | 655.6% | 1,999.9% | 153,176.3% | 31,055.8% | 18,972.3% | — | — | — |
| SG&A / revenue | 624.9% | 658.1% | 530.1% | 1,411.2% | 100,000.0% | 18,544.2% | 14,258.6% | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | — | — | — | — | 79,433.7 | — | — | — | — | — |
| Days of inventory on hand | — | — | — | — | 3,091.0 | — | — | — | — | — |
| Days payables outstanding | 797.9 | 687.6 | 2,912.2 | 1,764.5 | 838.8 | 65.8 | 78.7 | 8,701.5 | 324.1 | 458.3 |
| Cash conversion cycle (days) | — | — | — | — | 81,686.0 | — | — | — | — | — |
| Receivables turnover | — | — | — | — | 0.00 | — | — | — | — | — |
| Payables turnover | 0.46 | 0.53 | 0.13 | 0.21 | 0.44 | 5.55 | 4.64 | 0.04 | 1.13 | 0.80 |
| Inventory turnover | — | — | — | — | 0.12 | — | — | — | — | — |
| Asset turnover | 0.07 | 0.06 | 0.07 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | — | — | — | — | $5.0M | — | — | — | — | — |
| Average payables | $5.2M | $3.7M | $5.6M | $5.2M | $1.4M | $1.1M | $1.7M | $1.2M | $1.4M | $2.1M |
| Average inventory | — | — | — | — | $5.0M | — | — | — | — | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from OCGN's annual financial statements (latest annual report filed March 4, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
OCGN valuation and financial ratios
It ended the year with $33.1 million of debt and $18.6 million in cash and short-term investments, net debt of $14.6 million.
See the OCGN income statement, the OCGN chart for price history, or the OCGN stock overview for the latest quote and news.
OCGN key metrics FAQ
How much debt does Ocugen have?
Ocugen had total debt of $33.1 million at the end of fiscal 2025.
What is Ocugen's free cash flow yield?
Ocugen generated -$57.1 million of free cash flow in fiscal 2025, a free cash flow yield of −14.1% on its market value at year-end ($405.2 million).
What is Ocugen's current ratio?
Ocugen's current ratio was 1.06 at the end of fiscal 2025: current assets were 1.06 times current liabilities.